A February 2026 study in the Journal of Clinical Endocrinology & Metabolism found an 11% higher fragility fracture risk in older adults with Type 2 diabetes using GLP-1 medications versus those using other diabetes medications - though this was a retrospective study documenting association, not proven causation
Its likely that GLP-1 RAs (or their combinations) will be part of a future MASH therapy regimen, given weight loss is the cornerstone treatment and GLP-1 causes weight loss plus some direct hepatic fat reduction
That tells you something
Every LipoEdge product, including the Glutathione API, carries a complete technical data stack: particle size characterisation by dynamic light scattering (DLS), zeta potential measurement, encapsulation efficiency analysis, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), FTIR spectroscopy, and HPLC-validated purity
If results from a research chemical product fall significantly below what clinical trials show for pharmaceutical semaglutide at equivalent doses, product quality is the most likely explanation
Investigators reported pancreatitis (acute or other type) events in 29 patients (0.3%) in the Wegovy group and 30 patients (0.3%) in the placebo group